ARCHIVES

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

This article is from The Cancer Letter archive.

Vol. 40 No. 38 | October 10, 2014

Download PDF Visit The Full Archive

Related Articles

Anamorelin Increases Body Mass In Two Global Phase III Trials

October 31, 2014

Rauscher Says He May Leave, But Will Stay Through June

February 6, 1976

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

It’s Official – UCLA Recognize As 19th Comprehensive Center

January 7, 1977

Beefed Up Centers Subcommittee Meets On Core Guidelines

December 2, 1977